Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Resminostat ± sorafenib in hepatocellular carcinoma progressing on sorafenib
DRKS00000376Phase 2Completed
- Sponsor
- 4SC AG
- Start
- Apr 2010
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of Resminostat, sorafenib in hepatocellular carcinoma (HCC), sponsored by 4SC AG. Started Apr 2010; status: completed.
02
Drugs
Resminostatsorafenib
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on DRKS00000376.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on DRKS00000376.